Pinto Á
*, Reig O, Iglesias C, Gallardo E, García del Muro X, Alonso T, Anguera G, Suárez C, Muñoz-Langa J, Villalobos-León L, Rodriguez-Sánchez Á, Lainez N, Martínez-Ortega E, Campayo M, Velastegui A, Rodríguez-Vida A, Villa-Guzmán JC, Mendez-Vidal MJ, Rubio G, García I, Capdevila L, Lambea J, Vazquez S, Fernández O, Hernando-Polo S, Cerezo S, Santander C, García-Marrero R, Zambrana F, González del Alba A, Lazaro-Quintela M, Castellano D, Chirivella I, Anido U, Viana A, Garcia A, Sotelo M, Garcia-Arévalo M, Garcia-Donas J, Hernandez C, Bolós MV, Llinares J, Climent MA.
Clinical Factors Associated With Long-Term Benefit in Patients With Metastatic Renal Cell Carcinoma Treated With Axitinib: Real-World AXILONG Study. Clin Genitourin Cancer 2022; 20(1): 25-34.